Multi‐biomarker approach to predict survival and adverse cardiovascular events among patients with heart failure with preserved ejection fraction

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2022) et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

(2022) Amir Razaghizad et al.   Journal of the American Heart Association

Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR –Preserved trial

(2022) Stuart J. Pocock et al.   EUROPEAN JOURNAL OF HEART FAILURE

Biomarkers in heart failure: Relevance in the clinical practice

(2022) Abdulaziz Joury et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction

(2021) Michael McDonald et al.   CANADIAN JOURNAL OF CARDIOLOGY

Tailored use of β blockers using artificial intelligence

(2021) Robert Avram et al.   LANCET

Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF

(2021) Mauro Gori et al.   JACC-Heart Failure

Utility of Biomarkers in Cardiac Amyloidosis

(2020) Arianna Pregenzer-Wenzler et al.   JACC-Heart Failure

Prediction of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes ( TRS‐HF DM ) in patients in the ACCORD trial

(2020) Malik Elharram et al.   DIABETES OBESITY & METABOLISM

A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction

(2018) Yogesh N. V. Reddy et al.   CIRCULATION

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

(2012) Stuart J. Pocock et al.   EUROPEAN HEART JOURNAL